Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study. (Q46179089)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study. |
scientific article |
Statements
Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study (English)
Catherine Thieblemont
Elisabeth Wassner-Fritsch
Krimo Bouabdallah
Reda Bouabdallah
Franck Andre Morschhauser
Philippe Solal-Céligny
Pierre Feugier
Guiyuan Lei